Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Martin Voss, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses updates on the progression towards individualizing therapy for metastatic renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.